Taglich Brothers’ 10th Annual Small Cap Equity Conference
Tuesday May 7th, 2013
January 2013
Aeolus Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on developing a platform of compounds for use in biodefense, fibrosis, oncology, infectious disease and diseases of the central nervous system.
